Morocco Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports

Morocco Pharmaceuticals and Healthcare Report

Morocco Pharmaceuticals and Healthcare Report - Business Monitor International - Industry Reports
Morocco Pharmaceuticals and Healthcare Report
Published Sep 10, 2016
99 pages — Published Sep 10, 2016
Price US$ 1,295.00  |  Buy this Report Now

About This Report

  
Abstract:

In July ----, doctors took to the streets in Rabat to protest against a law that would allow mutual health insurance companies to create their own care facilities and pharmacies, fearing the law would oppose the principle of competition and hurt existing healthcare practices. Also in July, the Ministry of Health announced that it will reduce the prices of medicines used to treat --- chronic diseases including inflammatory and infectious diseases, digestive system diseases, high cholesterol, asthma, and various infections. ...Also in July, the Ministry of Health announced that it will reduce the prices of medicines used to treat --- chronic diseases including inflammatory and infectious diseases, digestive system diseases, high cholesterol, asthma, and various infections. In May ----, the Moroccan government announced the completion of a number of agreements with local pharmaceutical associations, including plans to expand domestic manufacturing capacities on a national scale through the rollout of the country s first pharma-clusters. The International Diabetes Federation has reported that there were over -.-mn cases of diabetes in Morocco in ---- and that the number of deaths in adults (aged -----) due to the disease was -,--- in the same year. ...The International Diabetes Federation has reported that there were over -.-mn cases of diabetes in Morocco in ---- and that the number of deaths in adults (aged -----) due to the disease was -,--- in the same year. Moroccan pharmaceutical company Cooper International announced it will relocate to the Dubai Science

...A significant question mark hovers over whether the current healthcare funding model is sustainable, especially given the ageing population and high drug prices. Retail mark-ups for some chronic disease treatment have been capped to protect sufferers from debilitating healthcare costs. Corruption is seen as an issue across the industry as a whole. The government is expected to negotiate lower drug prices for the Regime d Assistance Medicale (RAMED) health insurance scheme for those most in need. Poorer harvesting conditions represents downside risk to economic growth forecasts, given the economy s reliance on agriculture. Unresolved political situation posing downside risks to the country s economic outlook, and thus also to its public sector spending. The proposed VAT hike on medicines poses a risk to pharmaceutical market development.

...� Business Monitor International Ltd Page - Pharmaceutical SWOT Analysis - Continued A growing middle class, with higher disposable incomes and greater health awareness, should support OTC sector and private health insurance. ...Strong growth prospects for generic drugs market, supported by government policies. Reduction of retail mark-ups and VAT for chronic illness medicines should improve access and thus consumption of such treatments. Introduction of patent protection has reduced the threat from unauthorised generic products. ...

  
Source:
Document ID
1758-4841
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Business Monitor International - Industry Reports—Established in 1984, Business Monitor International is a leading online publisher of specialist business information on global emerging markets. Business Monitor's range of quarterly services covers political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. Each Industry Report has been researched at source, and features latest-available data covering production, sales, imports and exports; 5-year industry forecasts through end-2012; company rankings and competitive landscapes for multinational and local manufacturers and suppliers; and analysis of latest industry developments, trends and regulatory changes.

About the Author


Cite this Report

  
MLA:
Business Monitor International - Industry Reports. "Morocco Pharmaceuticals and Healthcare Report" Sep 10, 2016. Alacra Store. Dec 07, 2016. <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Morocco-Pharmaceuticals-and-Healthcare-Report-2026-584>
  
APA:
Business Monitor International - Industry Reports. (2016). Morocco Pharmaceuticals and Healthcare Report Sep 10, 2016. New York, NY: Alacra Store. Retrieved Dec 07, 2016 from <http://www.alacrastore.com/storecontent/Business-Monitor-International-Industry-Reports/Morocco-Pharmaceuticals-and-Healthcare-Report-2026-584>
  
US$ 1,295.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Market Research from one place.